Skip to main content

Posts

Case Report: Inflammatory Myofibroblastic Tumor in a 6 Year-old Boy

  Introduction: Inflammatory myofibroblastic tumor (IMT) is a rare mesenchymal neoplasm characterized by spindle-shaped myofibroblastic cells accompanied by an inflammatory infiltrate. Although IMTs can occur at any age, they are more frequently diagnosed in children and young adults. This report presents a case of a 5-year-old boy from Bangladesh diagnosed with an IMT. Case Presentation: A 5-year-old boy from Bangladesh presented with difficulty walking and persistent pain in his right thigh for six months. In 2017, he underwent an excisional biopsy, and the lesion was initially diagnosed as fibrosarcoma. However, no treatment was initiated, and there was no consultation with a pediatric oncologist following the diagnosis. Clinical Progression: After 2.5 years, in 2019, the patient developed a new mass in the same area. MRI revealed an altered signal intensity lesion in the anterolateral aspect of the right upper thigh, suggestive of possible sarcoma. Surgical intervention was ...
Post a Comment
Read more
Recent posts

Childhood Malignancy in Bangladesh:Twelve Years Journey of a Tertiary care Specialized Cancer Hospital,

 
Post a Comment
Read more

Best Pediatric Oncologist of Bangladesh. Dr. Ashis Kumar Ghosh.

 
Post a Comment
Read more

Revaccination of children with cancer.

 https://medcraveonline.com/JPNC/JPNC-12-00468.pdf
Post a Comment
Read more

Relapse Nephroblastoma

 
Post a Comment
Read more

Metastatic medulloblastoma in 10-year-old girl treated successfully with chemotherapy without radiotherapy

l https://www.academia.edu/25681438/Metastatic_medulloblastoma_in_10_year_old_girl_treated_successfully_with_chemotherapy_without_radiotherapy?email_work_card=thumbnail This is a particular case of medulloblastoma that at onset did not receive standard therapy for medulloblastoma i.e. neither surgery nor craniospinal irradiation. This 10-year-old Chinese girl affected with localized medulloblastoma was previously treated at a medical department in China only with radiotherapy on the posterior fossa. When the child arrived in Italy with progressed metastatic medulloblastoma, she was treated with carboplatin/etoposide association i.v. followed by oral etoposide and partial surgery of the primitive mass. The schedule of chemotherapy was etoposide 300 mg/sqm followed by carboplatin 1000 mg/sqm in one day every 21–28 days for the first six courses, then etoposide 200 mg/sqm and carboplatin 600 mg/sqm in one day every 28–35 days for further 11 courses and oral etoposide 50 mg/sqm/day for ten...
Post a Comment
Read more